Common medical conditions among the elderly, such as congestive heart failure, chronic obstructive pulmonary disease, acute infection, atherosclerotic vascular disease, and minor lower extremity injury, increase the risk of VTE. [6] [7] [8] [9] [10] Frailty also predisposes the elderly to VTE. 11 In this study, we describe the clinical characteristics, prophylaxis, and initial treatment of 1932 elderly patients enrolled in the 183-center US DVT registry of patients with ultrasound-confirmed DVT. 12 
Methods

Patient Population
The DVT registry enrolled 5451 consecutive patients with ultrasound-confirmed DVT from October 2001 to March 2002. 12 Data were collected regarding baseline characteristics, comorbidities, VTE risk factors, prophylaxis prior to the diagnosis of DVT, and initial treatment strategies. The sole inclusion criterion was the confirmation of DVT by venous V enous thromboembolism (VTE) is a major source of morbidity and mortality among the elderly. Elderly patients have a high prevalence of impaired mobility and hospitalizations for medical illness that contributes to the development of VTE. 1 The incidence of VTE increases markedly with advancing age, and pulmonary embolism (PE) accounts for a greater proportion of VTE as age increases. 2 Advanced age is an independent predictor of mortality, 3, 4 with 1-year rate as high as 39% for PE and 21% for deep-vein thrombosis (DVT). 5 Venous thromboembolism, including deep-vein thrombosis and pulmonary embolism, is a major source of morbidity and mortality among elderly patients. To improve our understanding of elderly patients with deep-vein thrombosis, we compared 1932 patients with deep-vein thrombosis aged 70 years or older with 2554 nonelderly patients in a prospective registry of consecutive ultrasound-confirmed deep-vein thrombosis patients. The mean age of elderly patients was 78.9 ± 6.1 years compared with 51.8 ± 12.9 years in nonelderly (P < .0001). Elderly patients were more likely to have prior recent hospitalization (49.2% vs 44.7%, P = .03), congestive heart failure (20.5% vs 9.9%, P < .0001), chronic obstructive pulmonary disease (18.2% vs 11.7%, P < .0001), and recent immobilization (50.5% vs 39.6%, P < .0001) than the nonelderly patients. Elderly patients were less likely to present with typical deep-vein thrombosis symptoms of extremity discomfort (44.4% vs 60.6%, P < .0001) and difficulty ambulating (8.4% vs 11.2%, P = .002). Only 41% of elderly patients subsequently diagnosed with deep-vein thrombosis had received any venous thromboembolism prophylaxis. In conclusion, elderly patients with deep-vein thrombosis represent a particularly vulnerable population with numerous comorbid conditions. Diagnosis can present a challenge because typical deep-vein thrombosis symptoms may be absent. Fewer than 50% of elderly patients with deep-vein thrombosis had received any venous thromboembolism prophylaxis.
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Patients aged 70 years or older were classified as elderly, and those patients who were younger than 70 years were classified as nonelderly. We excluded 965 patients for whom data regarding age were missing or incomplete. However, these patients were similar to the reported cohort regarding comorbidities, risk factors, clinical presentation, prophylaxis, and initial treatment.
Data Collection
Data were extracted from medical records at each study site and recorded on case report forms by designated study coordinators. Presenting symptoms were determined by patient self-report as noted in the medical record. For each site that enrolled 3 or more patients, an independent auditor conducted at least 1 site visit to confirm the ultrasound diagnosis of DVT and review the medical records to ensure accuracy. A standardized method of venous ultrasound interpretation was used, requiring noncompressibility of the vein to establish the diagnosis of DVT. 13 Pulmonary embolism was diagnosed when confirmed by a high-probability ventilation-perfusion lung scan, contrast-enhanced chest computed tomogram, or conventional contrast pulmonary angiogram. Investigational review board approval was obtained from all 183 study sites.
Statistical Methods
The mean and standard deviation were calculated for continuous variables. Student's t test was used to assess differences in means. Categorical variables were compared using the chi-square test or Fisher's exact test. All tests were 2-tailed, and a P value of less than .05 was considered to be statistically significant. All statistical analyses were performed using STATA version 9.2 (STATA Corp, College Station, Texas).
Results
Baseline Characteristics
The mean age of elderly patients was 78.9 ± 6.1 years compared with 51.8 ± 12.9 years in the nonelderly (P < .0001; Table 1 ). Elderly patients were more often women and had a lower mean body mass index (25.8 ± 6 kg/m 2 vs 28.3 ± 8 kg/m 2 , P < .0001; Figure 1 ). Patients hospitalized for illness other than VTE and who subsequently developed DVT were more likely to be elderly than nonelderly (55.6% vs 48.1%, P < .0001).
Comorbidities and Risk Factors
Elderly patients with DVT were more likely to have neurological disease including stroke (30.5% vs 21%, P < .0001), osteoarthritis (25% vs 13.4%, P < .0001), acute lung disease including pneumonia (20.6% vs 14.3%, P = .0001), gastrointestinal bleed requiring transfusion (6.6% vs 3.8%, P = .002), or acute coronary syndrome (6.4% vs 3.8%, P = .004; Table 2 ). Elderly patients were more likely to have immobilization within 30 days of DVT diagnosis (50.5% vs 39.6%, P < .0001), prior hospitalization (49.2% vs 44.7%, P = .03), congestive heart failure (20.5% vs 9.9%, P < .0001), or chronic obstructive pulmonary disease (18.2% vs 11.7%, P < .0001; Table 2 ). 
Clinical Presentation of Venous Thromboembolism
Elderly patients were less likely to present with typical DVT symptoms such as extremity discomfort (44.4% vs 60.6%, P < .0001) and difficulty ambulating (8.4% vs 11.2%, P = .002; Table 3 ). Although more likely to report dyspnea (20.7% vs 18.2%, P = .04), elderly patients were less likely to present with chest pain (5.9% vs 8.7%, P = .0007).
Prophylaxis of Venous Thromboembolism
Elderly patients were more likely to receive VTE prophylaxis prior to developing DVT (41% vs 34.5%, P < .0001; Table 4 ). However, the frequency of VTE prophylaxis among elderly patients was low, with fewer than 50% receiving any prophylactic measures. Of the elderly patients initially hospitalized for illness other than VTE or immobilized within 30 days of the diagnosis of DVT, only 50% had received any VTE prophylaxis. Elderly patients were less likely to receive pneumatic compression devices (15.3% vs 19.9%, P = .01) or low-molecular weight heparin (LMWH) prophylaxis (15.1% vs 18.7%, P = .04) than nonelderly patients.
Treatment of Venous Thromboembolism
Elderly patients diagnosed with DVT were less likely to be treated exclusively as outpatients (16.3% vs 21.2%, P = .005; Table 5 ). They were also less likely to receive LMWH bridging than nonelderly patients (36.5% vs 41.3%, P = .001). Elderly patients with DVT underwent inferior vena cava (IVC) filter placement more often than nonelderly patients (17.9% vs 12.5%, P < .0001).
Discussion
This large real-world registry highlights several distinctions between elderly and nonelderly patients with DVT. Elderly patients were less likely to present with typical DVT symptoms such as extremity discomfort. Furthermore, they were less likely to report chest pain, a cardinal presenting symptom of PE. Elderly patients suffered from congestive heart failure and chronic obstructive pulmonary disease more often and were more likely to have been recently immobilized than the nonelderly. Fewer than 50% of elderly patients had received any VTE prophylaxis prior to the development of DVT. Once the diagnosis of DVT was established, elderly patients were more likely to be hospitalized rather than to be treated as outpatients. Venous thromboembolism may be devastating for elderly patients who often have a reduced ability to compensate for the hemodynamic and ventilatory demands of PE. 14 In one registry analysis, 50% of patients with fatal PE were 80 years or older. 1 Elderly patients also have an increased risk of recurrent DVT or PE compared with the nonelderly. 1 Difficulty diagnosing DVT and worse outcomes make preventive efforts, especially, important in the elderly. 15, 16 The American College of Chest Physicians and the International Union of Angiology guidelines have been published and define appropriate VTE prophylaxis. 17, 18 Nevertheless, similar to other registry analyses, [19] [20] [21] [22] we observed a low rate of VTE prophylaxis in both elderly and nonelderly patients who subsequently developed DVT. Meta-analyses evaluating pharmacologic prophylaxis in trials that enrolled elderly patients have demonstrated the safety and efficacy of low-dose anticoagulation. 23, 24 Mechanical prophylaxis has been shown to reduce VTE rates without an increased risk of bleeding. [25] [26] [27] [28] Despite these data, we observed low rates of pneumatic compression device (15.3%) and graduated compression stocking (12.5%) use among elderly patients who subsequently developed DVT. Elderly patients were more likely to undergo IVC filter placement than nonelderly. Increased use of IVC filters in elderly patients may result from concerns of the bleeding complications of anticoagulant therapy. Retrievable IVC filters may be helpful in elderly patients with VTE and transient contraindications to anticoagulation. 29 Our registry analysis is limited by the exclusion of patients for whom data regarding age were missing. These subjects were similar regarding comorbidities, risk factors, clinical presentation, prophylaxis, and initial treatment. Nevertheless, selection bias cannot be excluded. In addition, unrecognized confounding may be present despite extensive evaluation of patient characteristics. The frequency of PE was likely underestimated because the registry did not require evaluation for PE. The diagnoses of DVT and PE were not centrally adjudicated, raising the possibility of misdiagnosis. However, an independent auditor reviewed the medical records and confirmed the ultrasound diagnosis of DVT of patients at all study sites that enrolled 3 or more participants. Finally, this registry did not provide data on patient outcome or survival.
The methodology used in our study is consistent with published criteria for evaluating the scientific value of clinical data registries. 30 Consecutive patients with ultrasound-confirmed DVT were enrolled from diverse clinical sites including urban, suburban, and rural medical centers throughout the United States. Deep-vein thrombosis was diagnosed using the standardized ultrasound criterion of venous noncompressibility. 13 In summary, numerous comorbid conditions, multiple VTE risk factors, and atypical presentations establish elderly patients as particularly vulnerable to the development of DVT. Despite a high prevalence of risk factors contributing to the development of VTE as well as frequent recent hospitalization, elderly patients have an unacceptably low rate of prophylaxis. 
